Renal Cell Carcinoma Associated With Xp11.2 Translocation/TFE3 Gene-fusion: A Long Response to mammalian target of rapamycin (mTOR) Inhibitors

We believe that mTOR inhibitors could be a good line option treatment to consider for this type of patients.